 LOS ANGELES, CA ACCESSWIRE March 17, 2021 SNN Network, The Official Small-, Micro- and Nano-Cap News SourceTM, today published a new Video Interview with David Johnson, Chairman, and CEO of Enveric Biosciences NASDAQ:ENVB, a patient-first biotechnology company developing novel cannabinoid medicines to improve quality of life for cancer patients, according to the companys website see here: Click the following link to watch the Video Interview: Enveric Biosciences on Acquisition of Exclusive License from Diverse Biotech and Value Catalysts Moving Forward You can follow SNN Network on FACEBOOK, TWITTER, LINKEDIN, YOUTUBE Please review important disclosures on our website at About Enveric Biosciences Enveric Biosciences is a patient-first biotechnology company developing rigorously tested, novel cannabinoid medicines to improve quality of life for cancer patients. 